Sonoma Pharmaceuticals (SNOA) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.26
-0.87
-0.47
-0.07

Details

Expected EPS
-0.8
Actual EPS
-0.618047
Surprise EPS
0.18
Surprise Percent
+22.74%

Description

Sonoma Pharmaceuticals (SNOA) has reported earnings of -0.618047 per share for Q4 2024.

0 Comments

Share your thoughts